These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21054666)

  • 1. Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients.
    Nagano M; Fukami K; Yamagishi S; Sakai K; Kaida Y; Matsumoto T; Hazama T; Tanaka M; Ueda S; Okuda S
    Nephrology (Carlton); 2011 Mar; 16(3):299-303. PubMed ID: 21054666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients.
    Adachi T; Fukami K; Yamagishi S; Kaida Y; Ando R; Sakai K; Adachi H; Otsuka A; Ueda S; Sugi K; Okuda S
    Nephrology (Carlton); 2012 Nov; 17(8):689-94. PubMed ID: 22804770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients.
    Nongnuch A; Davenport A
    Nephrology (Carlton); 2015 Nov; 20(11):862-7. PubMed ID: 26014842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease.
    Ueno H; Koyama H; Fukumoto S; Tanaka S; Shoji T; Shoji T; Emoto M; Tahara H; Inaba M; Kakiya R; Tabata T; Miyata T; Nishizawa Y
    Metabolism; 2011 Apr; 60(4):453-9. PubMed ID: 20494372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Artif Organs; 2013 Jul; 37(7):E114-22. PubMed ID: 23635017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin autofluorescence associates with vascular calcification in chronic kidney disease.
    Wang AY; Wong CK; Yau YY; Wong S; Chan IH; Lam CW
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1784-90. PubMed ID: 24876353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients.
    Jung ES; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    J Korean Med Sci; 2017 Jan; 32(1):54-59. PubMed ID: 27914132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Yilmaz FM; Akay H; Duranay M; Yilmaz G; Oztekin PS; Koşar U; Tekeli N; Altay M; Parpucu H; Yücel D
    Clin Biochem; 2007 Dec; 40(18):1361-6. PubMed ID: 17936258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.
    Jiang J; Chen P; Chen J; Yu X; Xie D; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Yang X; Zhang Y; Zhang Y; Liang X; Zhang Z; Lin Q; Yu Y; Miyata T; Tian J; Liang M; Luo W; Xu X; Hou F
    Atherosclerosis; 2012 Sep; 224(1):187-94. PubMed ID: 22857897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum albumin, C-reactive protein and carotid atherosclerosis as predictors of 10-year mortality in hemodialysis patients.
    Kato A; Takita T; Furuhashi M; Maruyama Y; Hishida A
    Hemodial Int; 2010 Apr; 14(2):226-32. PubMed ID: 20345387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydial infection and progression of carotid atherosclerosis in patients on regular haemodialysis.
    Kato A; Takita T; Maruyama Y; Hishida A
    Nephrol Dial Transplant; 2004 Oct; 19(10):2539-46. PubMed ID: 15280523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum pentosidine with arterial stiffness in hemodialysis patients.
    Zhou Y; Yu Z; Jia H; Sun F; Ma L; Guo R; Peng L; Cui T
    Artif Organs; 2010 Mar; 34(3):193-9. PubMed ID: 20447043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence is a predictor of cardiovascular disease in chronic kidney disease patients.
    Furuya F; Shimura H; Takahashi K; Akiyama D; Motosugi A; Ikegishi Y; Haraguchi K; Kobayashi T
    Ther Apher Dial; 2015 Feb; 19(1):40-4. PubMed ID: 25545539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nutritional status, comorbidity, and inflammation in hemodialysis].
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
    Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects.
    Tahara N; Yamagishi S; Matsui T; Takeuchi M; Nitta Y; Kodama N; Mizoguchi M; Imaizumi T
    Cardiovasc Ther; 2012 Feb; 30(1):42-8. PubMed ID: 20626403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
    Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
    Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.